Core Insights - Pangea Natural Foods Inc. announces a strategic collaboration with Dr. Neal Davies and Dr. Raimar Loebenberg to enhance non-injectable peptide delivery systems for consumer wellness applications [1][5] Group 1: Collaboration Details - Amino Innovations, a subsidiary of Pangea, will leverage the expertise of two renowned pharmaceutical scientists to accelerate research and development [1][2] - The collaboration will utilize the University of Alberta's Drug Development and Innovation Centre for formulation and validation [2] Group 2: Research Scope - The partnership aims to establish benchmarks for precision peptide delivery across various formulations, including oral, dermal, and topical [3] - Research will focus on the absorption, bioavailability, and stability of peptides like BPC-157, GHK-Cu, and KPV, using natural enhancers [3][4] Group 3: Strategic Goals - The data generated will enhance Amino Innovations' intellectual property portfolio and regulatory credibility, facilitating new product development in nutraceutical and cosmeceutical markets [4] - The collaboration is expected to create scientific transparency in the wellness industry by generating pharmacokinetic and permeability data [5][6]